These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30842036)

  • 21. Bilateral subthalamic deep brain stimulation after bilateral pallidal deep brain stimulation for Parkinson's disease.
    Deogaonkar M; Monsalve GA; Scott J; Ahmed A; Rezai A
    Stereotact Funct Neurosurg; 2011; 89(2):123-7. PubMed ID: 21336008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local field potential recordings in a non-human primate model of Parkinsons disease using the Activa PC + S neurostimulator.
    Connolly AT; Muralidharan A; Hendrix C; Johnson L; Gupta R; Stanslaski S; Denison T; Baker KB; Vitek JL; Johnson MD
    J Neural Eng; 2015 Dec; 12(6):066012. PubMed ID: 26469737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: A Prospective Long-Term Study of Patient's Preferences.
    Furlanetti L; Raslan A; Khaleeq T; Hasegawa H; Tambirajoo R; Samuel M; Ashkan K
    Stereotact Funct Neurosurg; 2020; 98(1):43-47. PubMed ID: 32069466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease.
    Anheim M; Fraix V; Chabardès S; Krack P; Benabid AL; Pollak P
    Mov Disord; 2007 Dec; 22(16):2436-9. PubMed ID: 17960811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation.
    Quinn EJ; Blumenfeld Z; Velisar A; Koop MM; Shreve LA; Trager MH; Hill BC; Kilbane C; Henderson JM; Brontë-Stewart H
    Mov Disord; 2015 Nov; 30(13):1750-8. PubMed ID: 26360123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial Results of Bilateral Subthalamic Nucleus Stimulation for Parkinson Disease in a Newly Established Center in a Developing Country: Shiraz, Southern Iran.
    Razmkon A; Yousefi O; Rezaei R; Salehi S; Petramfar P; Mani A; Rahmati H; Vaidyanathan J; Ilami G; Amirmoezzi Y
    World Neurosurg; 2019 Jan; 121():e129-e135. PubMed ID: 30236810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
    Odekerken VJ; Boel JA; Schmand BA; de Haan RJ; Figee M; van den Munckhof P; Schuurman PR; de Bie RM;
    Neurology; 2016 Feb; 86(8):755-61. PubMed ID: 26819458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient perspectives on the efficacy of a new kind of rechargeable deep brain stimulators(1).
    Jia F; Hao H; Meng F; Guo Y; Zhang S; Zhang J; Li L
    Int J Neurosci; 2016 Nov; 126(11):996-1001. PubMed ID: 27435521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Efficacy of Bilateral Deep Brain Stimulation Does Not Change After Implantable Pulse Generator Replacement but the Impedances Do: A Prospective Study.
    Niemann M; Schneider GH; Kühn A; Vajkoczy P; Faust K
    Neuromodulation; 2020 Jun; 23(4):530-536. PubMed ID: 31323173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Relationship of Electrophysiologic Subthalamic Nucleus Length as a Predictor of Outcomes in Deep Brain Stimulation for Parkinson Disease.
    Shenai MB; Patel DM; Romeo A; Whisenhunt JD; Walker HC; Guthrie S; Guthrie BL
    Stereotact Funct Neurosurg; 2017; 95(5):341-347. PubMed ID: 28982098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Syrkin-Nikolau J; Koop MM; Prieto T; Anidi C; Afzal MF; Velisar A; Blumenfeld Z; Martin T; Trager M; Bronte-Stewart H
    Neurobiol Dis; 2017 Dec; 108():288-297. PubMed ID: 28890315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease.
    Swann NC; de Hemptinne C; Miocinovic S; Qasim S; Ostrem JL; Galifianakis NB; Luciano MS; Wang SS; Ziman N; Taylor R; Starr PA
    J Neurosurg; 2018 Feb; 128(2):605-616. PubMed ID: 28409730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Tesla MRI in patients with fully implanted deep brain stimulation devices: a preliminary study in 10 patients.
    Sammartino F; Krishna V; Sankar T; Fisico J; Kalia SK; Hodaie M; Kucharczyk W; Mikulis DJ; Crawley A; Lozano AM
    J Neurosurg; 2017 Oct; 127(4):892-898. PubMed ID: 28009238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease.
    Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z
    J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep Brain Stimulation Generator Replacement in End-Stage Parkinson Disease.
    Carlson JD; Palmer M; Hoefer A; Cox E; McLeod P; Mark J; Aldred J
    World Neurosurg; 2019 Aug; 128():e683-e687. PubMed ID: 31059853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.